Similarly for the TCGA exome samples, splice-site mutations in TP53, which are known to drive cancer (Varley et al., 2001; Lee et al., 2010), correlated with differences in gene expression levels (q = 2.3 × 10−2, Fisher’s method). The gene discussed is TP53; the disease is cancer.